Leucoencefalopatía multifocal progresiva en el curso de terapia combinada con bendamustina y rituximab

Rosas Cancio-Suárez, Marta; Barbolla Díaz, Ignacio; González-García, Andrés.
Med. clín (Ed. impr.) ; 155(11): 513-514, dic. 2020.
Artículo en Español | IBECS (España) | ID: ibc-198349

Documentos relacionados

  1. Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine.
  2. Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin-7.
  3. [Immune checkpoint inhibitors in the treatment of progressive multifocal leukoencephalopathy].
  4. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
  5. Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.
  6. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
  7. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
  8. A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report.
  9. Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation.
  10. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy.